A detailed history of First Personal Financial Services transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, First Personal Financial Services holds 1 shares of NBIX stock, worth $125. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Holding current value
$125
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$114.58 - $153.15 $114 - $153
1 New
1 $0
Q1 2022

May 02, 2022

BUY
$72.45 - $94.81 $2,028 - $2,654
28 New
28 $3,000
Q2 2018

Aug 07, 2018

SELL
$75.3 - $105.99 $45,631 - $64,229
-606 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$75.88 - $92.43 $11,533 - $14,049
-152 Reduced 20.05%
606 $50,000
Q4 2017

Jan 25, 2018

BUY
$58.53 - $77.59 $3,980 - $5,276
68 Added 9.86%
758 $59,000
Q3 2017

Nov 01, 2017

BUY
$47.97 - $61.28 $33,099 - $42,283
690
690 $42,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track First Personal Financial Services Portfolio

Follow First Personal Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on First Personal Financial Services with notifications on news.